… We also discuss the advantages as well as the limitations of these tumor-targeting … in the
development of bacteria and their outer membrane vesicles as drug carriers for cancer therapy. …

… enabled the use of bacterial outer membrane vesicles (OMVs) to … bacterial membrane.
Future work should verify and extend our findings by checking for systemic toxicity or toxic effects …

… The therapeutic effects were studied using the CT26 model. The tumor inhibition rate of
LOMV@PD-1 reached ≈70%, which was only 44% in the anti-PD-L1+LOMV group (Figure S14a…

… bacteria, known as cytoplasmic membrane vesicles (CMVs), are derived from the cytoplasmic
membrane, … Prophage-triggered membrane vesicle formation through peptidoglycan …

… are called outer membrane vesicles (OMVs), whereas BMVs produced by … bacteria are
released from the cellular membrane of the bacterium and are referred to as membrane vesicles (…

… In a mouse model of bacterium-induced peritonitis, we … -loaded vesicles and artificial cell
membrane vesicles. We … pathways and pathogens may benefit the therapy of peritonitis. Our …

… or as membrane vesicles when released by Gram-positive bacteria. Bacteria derived EVs
can affect host immunity with pathogenic bacteria derived EVs having pro-inflammatory effects …

… We herein propose a bioengineering approach where bacterial outer membrane vesicles
(OMVs) … (a) Illustration of the therapeutic scheme for validating the protective effects of ORFT …

… Extracellular vesicles (EV), also known as membrane vesicles, … bacteria. Several reports
suggest that archaea, gram-negative bacteria, and eukaryotic cells secrete membrane vesicles …

An effective tumor vaccine vector that can rapidly display neoantigens is urgently needed.
Outer membrane vesicles (OMVs) can strongly activate the innate immune system and are …